v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,734 $ 12,598
Accounts receivable, net of allowance for credit losses 2,314 2,149
Contract assets 3,391 2,226
Inventories 1,568 2,115
Assets held for sale 510
Other current assets 367 898
Total current assets 16,884 19,986
Property, plant and equipment, net 10,573 11,699
Other assets 52 1
Total assets 27,509 31,686
Current liabilities:    
Accounts payable 642 679
Accrued expenses 1,188 2,236
Current maturities of long-term debt 181 87
Contract liabilities 773 3,135
Total current liabilities 2,784 6,137
Long-term debt, net of current portion 181
Total liabilities 2,784 6,318
Contingencies (see note 14)
Stockholders’ equity:    
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,937,338 at December 31, 2025 and 6,881,838 at December 31, 2024 69 69
Additional paid-in capital 30,699 29,757
Accumulated deficit (6,043) (4,458)
Total stockholders’ equity 24,725 25,368
Total liabilities and stockholders’ equity $ 27,509 $ 31,686